Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology.

Autor: Zesiewicz TA, Elble R, Louis ED, Hauser RA, Sullivan KL, Dewey RB Jr., Ondo WG, Gronseth GS, Weiner WJ, American Academy of Neurology

Publikováno v: Neurology; 2005 Jun 28, Vol. 64 Issue 12, p2008-2020, 13p

Movement disorders after head injury: diagnosis and management.

Autor: O'Suilleabhain P, Dewey RB Jr.

Publikováno v: Journal of Head Trauma Rehabilitation; Jul/Aug2004, Vol. 19 Issue 4, p305-313, 9p

Accuracy of clinical detection of INO in MS: corroboration with quantitative infrared oculography.

Autor: Frohman TC, Frohman EM, O'Suilleabhain P, Salter A, Dewey RB Jr., Hogan N, Galetta S, Lee AG, Straumann D, Noseworthy J, Zee D, Corbett J, Corboy J, Rivera VM, Kramer PD, Frohman, T C, Frohman, E M, O'Suilleabhain, P, Salter, A, Dewey, R B Jr

Publikováno v: Neurology; 2003 Sep 23, Vol. 61 Issue 6, p848-850, 3p

Management of motor complications in Parkinson's disease.

Autor: Dewey RB Jr., Dewey, Richard B Jr

Publikováno v: Neurology; 2004 Mar 23 Supplement 4, Vol. 62 Issue 6, pS3-7, 1p

Correction: Evidence of brain target engagement in Parkinson's disease and multiple sclerosis by the investigational nanomedicine, CNM- Au8, in the REPAIR phase 2 clinical trials.

Autor: Ren J; Department of Neurology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX, 75390, USA., Dewey RB 3rd; Department of Neurology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX, 75390, USA.; Parkinson's Disease and Movement Disorders Center, Boca Raton, FL, 33486, USA., Rynders A; 3Clene Nanomedicine, Inc., 6550 S Millrock Dr., Suite G50, Salt Lake City, UT, 84121, USA., Evan J; 3Clene Nanomedicine, Inc., 6550 S Millrock Dr., Suite G50, Salt Lake City, UT, 84121, USA., Evan J; 3Clene Nanomedicine, Inc., 6550 S Millrock Dr., Suite G50, Salt Lake City, UT, 84121, USA., Ligozio S; Instat Clinical Research, A Veristat Company, 1 Wilson St., Chatham, NJ, 07928, USA., Ho KS; 3Clene Nanomedicine, Inc., 6550 S Millrock Dr., Suite G50, Salt Lake City, UT, 84121, USA. karen@clene.com., Sguigna PV; Department of Neurology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX, 75390, USA., Glanzman R; 3Clene Nanomedicine, Inc., 6550 S Millrock Dr., Suite G50, Salt Lake City, UT, 84121, USA., Hotchkin MT; 3Clene Nanomedicine, Inc., 6550 S Millrock Dr., Suite G50, Salt Lake City, UT, 84121, USA., Dewey RB Jr; Department of Neurology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX, 75390, USA.; Parkinson's Disease and Movement Disorders Center, Boca Raton, FL, 33486, USA., Greenberg BM; Department of Neurology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX, 75390, USA.

Publikováno v: Journal of nanobiotechnology [J Nanobiotechnology] 2024 Jan 03; Vol. 22 (1), pp. 16. Date of Electronic Publication: 2024 Jan 03.